Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality Home
BiotechReality – Information Intelligence System for Biopharma
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #Clinical Data #FDA Approval #Cancer #Phase 3 Trials #Novo Nordisk

Editor's Desk

Artificial Intelligence News Research

A New AI Model Learns DNA’s Hidden Language

  • By Editor's Desk
  • 7 August 2024
ai dna

Ever since the double helix was discovered, researchers have worked to decipher the information contained inside DNA.

Tagged AI Models, DNA
Drugs News Research

New effective drug against flesh-eating bacteria

  • By Editor's Desk
  • 5 August 2024
staph header 1200x800 1 700x467 1

A new compound created by researchers at Washington University School of Medicine in St. Louis successfully cures bacterial infections in mice, including those that can cause [Read More…]

Tagged Flesh-Eating Bacteria
Immunology News Research

A discovery shows that lung repair after viral infections by a new population of macrophages

  • By Editor's Desk
  • 4 August 2024
lung repair

Although macrophages are widely recognized for their participation during the acute phase of respiratory viral infections, less is known about their activity during the post-inflammatory phase.

Tagged Lung Repair, Macrophages, viral infection
Artificial Intelligence Genetics Neuroscience News

Researchers developed AI-powered detection of genetic epilepsies over current genetic diagnosis

  • By Editor's Desk
  • 1 August 2024
detection of epilepsy

Numerous treatments are being developed to target the genes causing the more than 100 epilepsies that have been linked to a single gene mutation.

Tagged Epilepsy, neurological diseases
Neuroscience Research

Developing connections between neurons to maintain brain health

  • By Editor's Desk
  • 29 July 2024
neuron connections

Alzheimer’s disease, frontotemporal dementia, and Parkinson’s disease are among the neurodegenerative diseases that are characterized by the buildup of abnormal proteins.

Tagged Brain Health, Neurons
Neuroscience Research

Research identified brain circuits for placebo effect pain relief

  • By Editor's Desk
  • 26 July 2024
covid brain

The researchers then demonstrated that specific neurons and synapses along this pathway are highly activated when mice expect and experience pain relief, even in the absence of medication.

Tagged Brain, Placebo Effect
Genetics Artificial Intelligence Technology

Genetic diagnostics identifies 34 new genetic diseases

  • By Editor's Desk
  • 24 July 2024
genetic diagnostics

For the best possible care, ultra-rare illnesses need both sophisticated genetic tests and diverse clinical competence.

Tagged Artificial Intelligence, Genetic Diagnostics, Genetic Diseases
Research News

Latest research finds mechanism for skeletal muscle regeneration

  • By Editor's Desk
  • 23 July 2024
skeletal muscle

During the process of embryonic development, hundreds of specialized cells known as myoblasts fuse to become skeletal muscles.

Tagged Regeneration, Skeletal Muscle
Healthcare & Pharmaceuticals News Research

Research promises a universal flu vaccine

  • By Editor's Desk
  • 22 July 2024
vaccine vial image

Six out of eleven nonhuman primates who received an inoculation against the 1918 flu virus, which was prevalent a century ago, reportedly withstood exposure to H5N1, one of the worst viruses now circulating in the globe. On the other hand, six uninfected monkeys in the control group that were infected with the H5N1 virus died from the illness.

Tagged Universal Flu Vaccine
Research

Discovery of bacteria that can destroy Forever Chemicals

  • By Editor's Desk
  • 20 July 2024
antibiotic resistant bacteria

Per- and polyfluoroalkyl substances, or PFAS, are another name for forever chemicals. These compounds persist in the environment because of their strong carbon-fluorine chemical interactions.

Tagged Bacteria, Forever Chemicals

Posts navigation

← Older Posts
→ Newer Posts
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

MSD Oncology Pipeline Advances With First Phase 3 Data for Intismeran Autogene Plus KEYTRUDA and Sacituzumab Tirumotecan
Clinical Data Healthcare & Pharmaceuticals News Oncology

MSD Oncology Pipeline Advances With First Phase 3 Data for Intismeran Autogene Plus KEYTRUDA and Sacituzumab Tirumotecan

17 October 202617 October 2026
Editor's Desk
Regeneron Libtayo Dosing Update: CHMP Recommends EU Approval of Every-Six-Week Cemiplimab Regimen Across All Cancer Types
Regulatory Approval Healthcare & Pharmaceuticals News Oncology

Regeneron Libtayo Dosing Update: CHMP Recommends EU Approval of Every-Six-Week Cemiplimab Regimen Across All Cancer Types

16 October 202617 October 2026
Editor's Desk
Lilly Omvoh (mirikizumab-mrkz) Delivers Comprehensive Disease Control in Ulcerative Colitis and Deep Remission in Crohn’s Disease at One Year
Clinical Data Healthcare & Pharmaceuticals News

Lilly Omvoh (mirikizumab-mrkz) Delivers Comprehensive Disease Control in Ulcerative Colitis and Deep Remission in Crohn’s Disease at One Year

15 October 202615 October 2026
Editor's Desk
Charles River Magellan Collaboration Backs Zelestrocel Osteoarthritis Therapy With cGMP NGS Viral Safety Testing
Business Clinical Data Gene Therapy Healthcare & Pharmaceuticals News

Charles River Magellan Collaboration Backs Zelestrocel Osteoarthritis Therapy With cGMP NGS Viral Safety Testing

14 October 202614 October 2026
Editor's Desk
Johnson & Johnson Q3 2026 Results: J&J Raises 2026 Guidance as OTTAVA, IMAAVY and RYBREVANT FASPRO Advance
Business Healthcare & Pharmaceuticals News

Johnson & Johnson Q3 2026 Results: J&J Raises 2026 Guidance as OTTAVA, IMAAVY and RYBREVANT FASPRO Advance

13 October 202614 October 2026
Editor's Desk
IQVIA Veeva Clinical Operations Expansion: IQVIA Selects Veeva CTMS, eTMF, Study Startup and Site Connect as Enterprise Standards
Business Artificial Intelligence Clinical Data Healthcare & Pharmaceuticals News Research

IQVIA Veeva Clinical Operations Expansion: IQVIA Selects Veeva CTMS, eTMF, Study Startup and Site Connect as Enterprise Standards

13 October 202613 October 2026
Editor's Desk
Advertisement
BiotechReality JobFinder

  • Clinical Project Management Director – IQVIA
    16 October 2026
  • Senior Manager, Global Digital Marketing – Lonza
    11 October 2026
  • Commercial Product Manager – Centrifuge – ThermoFisher, Singapore & Malaysia
    7 October 2026
  • Regulatory Affairs Specialist – Lonza, Hyderabad
    4 October 2026
  • Component Engineer – Cytiva, Bangalore
    29 September 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter